|
Zhilyaeva Yu.A., Mikhin V.P., Nikolaevskaya A.O., Babkin M.O.
The role of metalloproteinases in the pathogenesis of cardiovascular diseases
|
№6 / 2024
|
|
Izmozherova N.V., Grenaderova M.A., Shambatov M.A., Popov A.A., Kudryavtseva E.V., Bortnik A.E., Vishneva K.A., Shamilov M.D.
The use of angiotensin II type 1 receptor antagonists in the treatment of chronic heart failure against the background of the renin-angiotensin-aldosterone system genetic polymorphisms
|
№1 / 2024
|
|
V.I. Petrov, O.V. Shatalova, M.S. Klykova, N.P. Stetsky
The use of sodium-glucose co-transporter type II (SGLT2) inhibitors in patients with chronic heart failure against the background of type 2 diabetes mellitus
|
№12 / 2023
|
|
V.S. Nikiforov
Possibilities of using trimetazidine in comorbid cardiovascular pathology and metabolic disorders
|
№13 / 2022
|
|
O.A. Polyakova (1), A.A. Chochua (1), O.V. Golovina (1), E.V. Mironova (2), O.D. Ostroumova (1)
Possibilities of using trimetazidine in the treatment of patients with ischemic heart disease and chronic heart failure
|
№13 / 2021
|
|
N.A. Karoli, A.P. Rebrov
Beta-blockers in patients with chronic obstructive pulmonary disease: for whom, when, how?
|
№5 / 2020
|
|
A.I. Dyadyk, Т.Е. Kugler, E.V. Schukina, I.V. Rakitskaya, S.R. Zborovsky, Yu.V. Suliman
DIURETHIC RESISTANCE: MECHANISMS, MEDICAL TACTICS AND PREVENTION
|
№18 / 2017
|
|
S.G. Kanorsky, A.F. Sereda
THE USE OF STATINES IN PATIENTS WITH ARTERIAL HYPERTENSION AND CHRONIC HEART FAILURE WITH PRESERVED LEFT VENTRICULAR EJECTION FRACTION
|
№15 / 2017
|
|
M.I. Ivanova (1), S.A. Bolduyeva (1), P.P. Ikonnikov (2)
CLINICAL CASE OF TRANSTHYRETIN AMYLOIDOSIS WITH HEART, PLEVURE AND KIDNEY INVOLVEMENT
|
№10 / 2017
|
|
S.G. Kanorsky, Yu.V. Borisenko
IVABRADIN AGAINST BISOPROLOL IN PATIENTS WITH CHRONIC HEART FAILURE AND PRESERVED LEFT VENTRICULAL EJECTION FRACTION
|
№6 / 2017
|
|
V.N. Larina, M.V. Leonova, I.I. Chukaeva
NEW EUROPEAN GUIDELINES ON PHARMACOTHERAPY OF CHRONIC HEART FAILURE AND EVIDENCE-BASED DATA
|
№18 / 2016
|
|
E.I. Astashkin, M.G. Glezer
ROLE OF DIFFERENT TYPES OF RENIN-ANGIOTENSIN SYSTEM IN PATHOGENESIS OF CARDIOVASCULAR DISEASES. FOCUS ON VALSARTAN
|
№13 / 2014
|
Русский
